Ticker: KALV

Company: KalVista Pharmaceuticals, Inc.

Person: Benjamin L Palleiko, director, officer

Transaction date: Nov. 17, 2024

Reporting date: Nov. 19, 2024

Average share price: -8.437371819217622

Sold 15798.0 shares for 133293.6